Overview
EnPlusOne Biosciences will revolutionize how RNA therapeutics & vaccines are accessed at scale by leveraging its novel enzymatic synthesis platform. This technology is poised to capitalize on the unprecedented demand for RNA and industry shift towards greener synthesis methods, ultimately serving the unmet needs of patients around the world.